Neurobiology of placebo effect in Parkinson's disease: What we have learned and where we are going

@article{Quattrone2018NeurobiologyOP,
  title={Neurobiology of placebo effect in Parkinson's disease: What we have learned and where we are going},
  author={A. Quattrone and G. Barbagallo and A. Cerasa and A. Stoessl},
  journal={Movement Disorders},
  year={2018},
  volume={33}
}
The placebo effect is a phenomenon produced when an inert substance administered like a regular treatment improves the clinical outcome. Parkinson's disease (PD) is one of the main clinical disorders for which the placebo response rates are high. The first evidence of the neurobiological mechanisms underlying the placebo effect in PD stems from 2001, when de la Fuente‐Fernandez and colleagues demonstrated that a placebo injection led to the release of dopamine in the striatal nuclei of PD… Expand
Placebo responses in Parkinson's disease.
  • J. Lou
  • Medicine
  • International review of neurobiology
  • 2020
Maximizing placebo response in neurological clinical practice.
Cerebral differences between dopamine-resistant and dopamine-responsive Parkinson's tremor.
Emerging drugs for the treatment of L-DOPA-induced dyskinesia: an update
Placebo effects in pain.
  • L. Colloca
  • Psychology, Medicine
  • International review of neurobiology
  • 2020
Effect of melatonin administration on the PER1 and BMAL1 clock genes in patients with Parkinson's disease.
...
1
2
...

References

SHOWING 1-10 OF 75 REFERENCES
How Placebos Change the Patient's Brain
Effects of expectation on placebo-induced dopamine release in Parkinson disease.
Molecular Mechanisms of Placebo Responses In Humans
The placebo-reward hypothesis: dopamine and the placebo effect.
Mind matters: Placebo enhances reward learning in Parkinson’s disease
...
1
2
3
4
5
...